Navigation Links
Treatment for fibroids with "Abortion Pill"

Women suffering form fibroids, who until now had only an option of a hysterectomy or removal of the fibroid, now have an alternative of shrinking the fibroid with the drug Mifepristone. Lead researcher Steven H. Eisinger, MD, said that fibroids are a common and vexing problem in women and fibroid relief accounts for about 30% of all hysterectomies in the U.S. Women who are symptomatic could have back pain, pain with intercourse, problems with bowels and bladder, and most especially heavy bleeding. Many of these women are also chronically// anemic.

Mifepristone was approved by the FDA in 2000 after a lot of controversies and since then studies have shown that the drug could be a possible contraceptive, a treatment for endometriosis, and a possible remedy for fibroids. Eisinger conducted a study with 20 women who all had large fibroids and multiple symptoms -- including heavy periods, pelvic pain and pressure, and lower back pain. The women were randomly asked to take either 5 mg or 10 mg of Mifepristone daily -- the very lowest doses. At the end of the study all women had a remarkable shrinkage of the fibroid, by about one-half. They also showed significant symptom relief.

An interesting fact about Mifepristone is that it stops monthly menstruation completely, giving many of these women with fibroids, who are chronically anemic, a chance to raise their blood count. They feel much better, healthier, and if they need surgery, they are much more likely to not require blood transfusion. Eisinger added that Mifepristone, compared to the currently available drug for fibroid-shrinking - Lupron (leuprolide acetate), would be cheaper and better tolerated and would work just as well. Lupron, used as a preoperative treatment to assist in the surgical removal of fibroids, decreases the body's production of estrogen to menopausal levels. Though this is useful in shrinking fibroids, side effects such as hot flashes and vaginal dryness can come with the estrog en decrease. Also Mifepristone has been shown in Eisinger's study as effective in all women, while it cannot be said so with Lupron. However, Elizabeth Ginsburg, MD, an Obstetrics/Gynecology and Fertility specialist at Brigham & Women's Hospital in Boston cautioned that there may be long-term safety issues connected with Mifepristone as almost a third of the women in Eisinger's study had developed hyperplasia of the lining of the uterus. Though, it is not a cancerous lesion, hyperplasia can become cancerous over many years' time.


'"/>




Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/20/2017)... ... 20, 2017 , ... Chuck E. Cheese’s® and Center for Autism and Related ... Chuck E. Cheese’s locations throughout New England, New York and New Jersey to provide ... the fun of visiting Chuck E. Cheese’s in a sensory-friendly environment. , After ...
(Date:2/19/2017)... ... February 19, 2017 , ... The Citadel’s new Swain Department ... being led by Amelia Joseph, Ph.D. Joseph was engaged by the college as a ... department in early 2016. After a nation-wide search, she was selected to head the ...
(Date:2/19/2017)... ... February 19, 2017 , ... ... result in better care, and MEDfx and the Delaware Health Information Network (DHIN) ... , As the nation’s first state-wide health information exchange, DHIN stores and shares ...
(Date:2/18/2017)... Waltham, Massachusetts (PRWEB) , ... February 17, 2017 ... ... be the leading source of disruptive innovation in the industry, according to the ... Insights Reports are based on surveys of the NEJM Catalyst Insights Council, a ...
(Date:2/18/2017)... ... February 17, 2017 , ... Park Cities Pet Sitter President, Joette White, ... Pet Life Radio network. The episode, which was posted this week, features a ... factors led to Park Cities Pet Sitter’s being awarded the 2017 National Association of ...
Breaking Medicine News(10 mins):
(Date:2/19/2017)... Feb. 19, 2017   AC Group Inc. , ... ranking of vendors in the PMS/EHR healthcare marketplace, will ... system requirements to succeed in this ecosystem at HIMSS,17. ... together information obtained from over 200 ACOs, compared and ... and services companies that are providing different pieces of ...
(Date:2/19/2017)... , February 18, 2017 Marapharm ... to purchase a Medical Delivery Service with the specific ... transactions between qualified patients and caregivers. The delivery service ... located in the Coachella Valley, California ... Los Angeles area to the West, population ...
(Date:2/18/2017)... Feb. 17, 2017   Parker Waichman ... the rights of victims injured by medical devices, ... to call for better reporting. Congress required hospitals ... Safety concerns involving power morcellators and duodenoscopes prompted ... investigate how hospitals report injuries and deaths related ...
Breaking Medicine Technology: